Rizatriptan Benzoate Tablet
NDC Package 64220-995-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Rizatriptan Benzoate tablets is rizatriptan is used to treat migraines. This formulation utilizes a tablet delivery system. Marketed by Zhejiang Huahai Pharmaceutical Co., Ltd, this product is identified by NDC 64220-995.

Identification & Billing

NDC Package Code
64220-995-00
Package Description
3 BAG in 1 DRUM / 52630 TABLET in 1 BAG
Product Code
64220-995
11-Digit Billing Format
64220099500

Clinical Specifications

Proprietary Name
Rizatriptan Benzoate
Non-Proprietary Name
Rizatriptan Benzoate
Substance Name
Rizatriptan Benzoate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Active Ingredient(s)
RIZATRIPTAN BENZOATE 10 mg/1
Usage Information
Rizatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Rizatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Rizatriptan does not prevent future migraines or lessen how often you get migraine attacks.

Regulatory & Marketing

Labeler Name
Zhejiang Huahai Pharmaceutical Co., Ltd
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING - A category specifying that a bulk product is intended for use on humans and requires a prescription.
Start Marketing Date
04-16-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64220-995-00 identifies a specific commercial package of 3 bag in 1 drum / 52630 tablet in 1 bag of Rizatriptan Benzoate (UNFINISHED drug), a bulk ingredient labeled by Zhejiang Huahai Pharmaceutical Co., Ltd. This tablet is formulated for use and contains rizatriptan benzoate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zhejiang Huahai Pharmaceutical Co., Ltd on April 16, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Rizatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Rizatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Rizatriptan does not prevent future migraines or lessen how often you get migraine attacks.

How is this Zhejiang Huahai Pharmaceutical Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64220099500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64220-995-00
11-Digit CMS (5-4-2)
64220-0995-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.